RarePipelinepeopleInnovationCollaborationCareersFinance Advance treatment Skip to main contentSkip to navigationSkip to search
Hansa Biopharma
HNSA (, %) SEK
Hansa Biopharma
Financial documents

Shareholders

Shareholders

Top 10 shareholders as of March 31, 2023

Name Number of sharesOwnership in pct
Redmile Group, LLC10,896,55320.8%
Försäkrings AB Avanza Pension2,509,5354.8%
Fjärde AP-Fonden (AP 4)2,207,3974.2%
Nexttobe AB2,155,3794.1%
Olausson, Thomas1,917,0003.7%
Tredje AP-Fonden (AP 3)1,389,6502.6%
Braidwell, L.P.974,5281.9%
C WorldWide Asset Management 799,7491.5%
Heights Capital Management, Inc.667,1691.3%
VOB & T Trading AB644,8001.2%
Other28,282,20253.9%
Total52,443,962100%

Source: IHS Markit/IPREO compiled and processed data from various sources, including Euroclear, Morningstar, Factset and the Swedish Financial Supervisory Authority (Finansinspektionen).

Hansa Biopharma had approximately 20,000 shareholders as of March 31, 2023.

Classification of ownership as per Dec 31, 2022

Region

53%
25%
22%

Category

57%
32%
7%
4%